Are you Dr. Milton?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 83 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8301 Harcourt Rd
Ste 200
Indianapolis, IN 46260Phone+1 317-415-6600Fax+1 317-415-6649
Summary
- Dr. Daniel Milton, MD is an oncologist in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, New York, and Illinois. He is affiliated with Ascension St. Vincent Carmel Hospital, Riverview Health, and Witham Health Services.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1998 - 2002
Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Certifications & Licensure
IN State Medical License 2007 - 2025
IL State Medical License 1998 - 2008
NY State Medical License 2002 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 8 citationsMulticenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.Craig L. Slingluff, Karl D. Lewis, Robert H.I. Andtbacka, John R. Hyngstrom, Mohammed M. Milhem
Journal for Immunotherapy of Cancer. 2021-10-01 - 232 citations2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung CancerChristopher G. Azzoli, Sarah Temin, Timothy Aliff, Sherman Baker, Julie R. Brahmer
Journal of Clinical Oncology. 2011-10-01 - 400 citationsAmerican Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell ...Vicki L. Keedy, Sarah Temin, Mark R. Somerfield, Mary Beth Beasley, David H. Johnson
Journal of Clinical Oncology. 2011-05-20
Press Mentions
Second COVID-19 Testing Machine to Be Installed at the Virology Lab at KGHApril 13th, 2020
